<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Moreira CHV</submitter><funding>NHLBI NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III) International Component</funding><funding>National Institute of Mental Health</funding><funding>WHI NIH HHS</funding><pagination>104-112</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8981372</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Acquisition of HIV primary drug resistant (PDR) infection can lead to poor virologic and clinical outcomes in individuals and hampers public health efforts in epidemic control. Monitoring PDR in HIV-positive blood donors can be used to inform nationwide trends in the spread of drug-resistant HIV strains.&lt;h4>Methods&lt;/h4>We conducted a cross-sectional study using genetic sequence analysis to assess HIV pol sequences, PDR, and risk factors for infection using audio computer-assisted structured interviews in four large blood centers in Brazil from 2007 to 2017.&lt;h4>Results&lt;/h4>Of 716 HIV-positive blood donors, 504 (70.4%) were successfully sequenced. HIV clade B (73.2%) was the most prevalent subtype, followed by a mix of non-B (21.2%) sub-types. A twofold increase (from 4% t</pubmed_abstract><journal>Transfusion medicine (Oxford, England)</journal><pubmed_title>HIV primary drug resistance and associated HIV risk factors among HIV positive blood donors in Brazil from 2007 to 2017.</pubmed_title><pmcid>PMC8981372</pmcid><funding_grant_id>HHSN 268201100007I</funding_grant_id><funding_grant_id>R25 MH123256</funding_grant_id><funding_grant_id>HHSN268201100007C</funding_grant_id><funding_grant_id>HHSN268201100001I</funding_grant_id><funding_grant_id>R25 MH064712</funding_grant_id><funding_grant_id>HHSN 268201100001I</funding_grant_id><funding_grant_id>HHSN268201100007I</funding_grant_id><funding_grant_id>HHSN268201100001C</funding_grant_id><pubmed_authors>Preiss L</pubmed_authors><pubmed_authors>Carneiro-Proietti AB</pubmed_authors><pubmed_authors>Salomon T</pubmed_authors><pubmed_authors>Teixeira CM</pubmed_authors><pubmed_authors>de Almeida-Neto C</pubmed_authors><pubmed_authors>Loureiro P</pubmed_authors><pubmed_authors>Lopes ME</pubmed_authors><pubmed_authors>Alencar CS</pubmed_authors><pubmed_authors>Goncalez TT</pubmed_authors><pubmed_authors>Mundim M</pubmed_authors><pubmed_authors>Custer B</pubmed_authors><pubmed_authors>Sabino EC</pubmed_authors><pubmed_authors>Moreira CHV</pubmed_authors></additional><is_claimable>false</is_claimable><name>HIV primary drug resistance and associated HIV risk factors among HIV positive blood donors in Brazil from 2007 to 2017.</name><description>&lt;h4>Background&lt;/h4>Acquisition of HIV primary drug resistant (PDR) infection can lead to poor virologic and clinical outcomes in individuals and hampers public health efforts in epidemic control. Monitoring PDR in HIV-positive blood donors can be used to inform nationwide trends in the spread of drug-resistant HIV strains.&lt;h4>Methods&lt;/h4>We conducted a cross-sectional study using genetic sequence analysis to assess HIV pol sequences, PDR, and risk factors for infection using audio computer-assisted structured interviews in four large blood centers in Brazil from 2007 to 2017.&lt;h4>Results&lt;/h4>Of 716 HIV-positive blood donors, 504 (70.4%) were successfully sequenced. HIV clade B (73.2%) was the most prevalent subtype, followed by a mix of non-B (21.2%) sub-types. A twofold increase (from 4% t</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2026-05-31T02:10:46.809Z</modification><creation>2025-04-04T23:04:12.088Z</creation></dates><accession>S-EPMC8981372</accession><cross_references><pubmed>33665900</pubmed><doi>10.1111/tme.12766</doi></cross_references></HashMap>